WallStreetZenWallStreetZen

NASDAQ: RNXT
Renovorx Inc Stock

$1.11-0.22 (-16.54%)
Updated Oct 2, 2023
RNXT Price
$1.11
Fair Value Price
N/A
Market Cap
$11.82M
52 Week Low
$0.91
52 Week High
$5.75
P/E
-1.05x
P/B
9.95x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$9.88M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
4.32
Operating Cash Flow
-$10M
Beta
0.93
Next Earnings
Nov 13, 2023
Ex-Dividend
N/A
Next Dividend
N/A

RNXT Overview

Renovorx Incorporated is a clinical-stage biopharmaceutical company developing treatments for solid tumor. The company's lead product is RenovoGem, a drug and device combination that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Renovorx was founded in 2009 and is headquartered in Los Altos, CA.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RNXT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RNXT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RNXT is poor value based on its book value relative to its share price (9.95x), compared to the US Biotechnology industry average (5.05x)
P/B vs Industry Valuation
RNXT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more RNXT due diligence checks available for Premium users.

Be the first to know about important RNXT news, forecast changes, insider trades & much more!

RNXT News

Valuation

RNXT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.05x
Industry
14.19x
Market
12.38x

RNXT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
9.95x
Industry
5.05x
RNXT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RNXT's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.3M
Profit Margin
0%
RNXT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$6.3M
Liabilities
$5.1M
Debt to equity
4.32
RNXT's short-term assets ($6.31M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RNXT's short-term assets ($6.31M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RNXT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.8M
Investing
$0.0
Financing
$5.0M
RNXT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RNXT vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
RNXT$11.82M-16.92%-1.05x9.95x
AEZS$11.95M-1.60%-0.53x0.41x
LABP$12.00M-0.75%-0.80x0.28x
TFFP$12.11M-4.57%-0.46x0.99x
ERNA$12.12M+2.75%-0.41x3.13x

Renovorx Stock FAQ

What is Renovorx's quote symbol?

(NASDAQ: RNXT) Renovorx trades on the NASDAQ under the ticker symbol RNXT. Renovorx stock quotes can also be displayed as NASDAQ: RNXT.

If you're new to stock investing, here's how to buy Renovorx stock.

What is the 52 week high and low for Renovorx (NASDAQ: RNXT)?

(NASDAQ: RNXT) Renovorx's 52-week high was $5.75, and its 52-week low was $0.91. It is currently -80.77% from its 52-week high and 21.43% from its 52-week low.

How much is Renovorx stock worth today?

(NASDAQ: RNXT) Renovorx currently has 10,693,080 outstanding shares. With Renovorx stock trading at $1.11 per share, the total value of Renovorx stock (market capitalization) is $11.82M.

Renovorx stock was originally listed at a price of $7.26 in Aug 26, 2021. If you had invested in Renovorx stock at $7.26, your return over the last 2 years would have been -84.78%, for an annualized return of -60.99% (not including any dividends or dividend reinvestments).

How much is Renovorx's stock price per share?

(NASDAQ: RNXT) Renovorx stock price per share is $1.11 today (as of Oct 2, 2023).

What is Renovorx's Market Cap?

(NASDAQ: RNXT) Renovorx's market cap is $11.82M, as of Oct 4, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Renovorx's market cap is calculated by multiplying RNXT's current stock price of $1.11 by RNXT's total outstanding shares of 10,693,080.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.